HomeCYCN • NASDAQ
add
Cyclerion Therapeutics Inc
Previous close
$3.24
Day range
$3.05 - $3.31
Year range
$1.27 - $9.47
Market cap
8.92M USD
Avg Volume
6.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 194.00K | — |
Operating expense | 1.32M | -51.24% |
Net income | -723.00K | -109.56% |
Net profit margin | -372.68 | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.87M | -68.47% |
Total assets | 8.90M | -41.51% |
Total liabilities | 700.00K | -70.10% |
Total equity | 8.20M | — |
Shares outstanding | 2.53M | — |
Price to book | 1.00 | — |
Return on assets | -29.74% | — |
Return on capital | -33.21% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -723.00K | -109.56% |
Cash from operations | -1.72M | 75.26% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.72M | -149.50% |
Free cash flow | -1.70M | 50.43% |
About
Founded
2018
Website
Employees
1
